Skip to main
VBLT
VBLT logo

Vascular Biogenics (VBLT) Market Capitalization Overview

Market Cap: $2.40M as of Sep 2, 2025

$2.40M
Past Month$0.00 (0.00%)
As of Sep 2, 2025, Vascular Biogenics (VBLT) has a market capitalization of $2.40M. Over the past 30 days, its market cap has increased by 0%, while in the last 12 months, it has increased by 0%.

Market capitalization represents the total value of Vascular Biogenics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Vascular Biogenics (VBLT) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Vascular Biogenics (VBLT) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Vascular Biogenics (VBLT) Market Cap History

DateMarket CapChange
Sep 2, 2025$2.40M0.00%
Aug 1, 2025$2.40M0.00%
Jul 1, 2025$2.40M0.00%
Jun 2, 2025$2.40M0.00%
May 1, 2025$2.40M0.00%
Apr 1, 2025$2.40M0.00%
Mar 3, 2025$2.40M0.00%
Feb 3, 2025$2.40M0.00%
Jan 2, 2025$2.40M0.00%

Vascular Biogenics (VBLT) End of Year Market Cap History

DateMarket CapChange
2025$2.40M0.00%
2024$2.40M-98.37%
2023$146.75M+1,653.17%
2022$8.37M-93.82%
2021$135.37M+49.53%
2020$90.53M

FAQs About Vascular Biogenics (VBLT) Market Cap

As of Sep 2, 2025, the market capitalization of Vascular Biogenics (VBLT) is $2.40M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Vascular Biogenics’s market capitalization has increased by 0.0000%, changing from $2.40M to $2.40M as of Sep 2, 2025.

In the last 3 months, Vascular Biogenics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Vascular Biogenics’s market capitalization decreased from $146.75M in January to $2.40M in December, reflecting a -98.37% change.

In the past five years, Vascular Biogenics (VBLT) has had a compound annual growth rate (CAGR) of -51.64% in market capitalization. This means its market cap has shrunk at an average rate of -51.64% per year.

Vascular Biogenics (VBLT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.